MTEM - スレッシュ・ホ―ルド・ファ―マス―ティカルズ (Molecular Templates Inc.)


   Molecular Templates reports Q4 results  2019-03-28
Molecular Templates (NASDAQ: MTEM ): Q4 GAAP EPS of $0.18. More news on: Molecular Templates, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …
   Molecular Templates launches mid-stage study of MT-3724 in DLBCL  2019-03-28
Molecular Templates ( MTEM +0.7% ) initiates a Phase 2 clinical trial evaluating MT-3724 in up to 100 patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who have received at least two prior lines of therapy. More news on: Molecular Templates, Inc., Healthcare stock…